Exhibit 99.1
| | |
| | KMG Chemicals, Inc. 9555 W. Sam Houston Parkway South Suite 600 Houston, TX 77099 USA |
KMG Chemicals Reports First Quarter 2014 Financial Results
HOUSTON, Texas—(BUSINESS WIRE)—December 10, 2013—KMG Chemicals, Inc. (NYSE: KMG), a global provider of specialty chemicals to select markets, today announced financial results for the fiscal 2014 first quarter ended October 31, 2013.
2014 First Quarter Financial Review
| • | | Net sales were $93.6 million, an increase of 43.3% from the comparable quarter in fiscal 2013. The sales increase reflected the addition of OM Group’s Ultra Pure Chemicals (UPC) business, acquired in May 2013. |
| • | | Adjusted EBITDA1 of $8.0 million, compared to $9.3 million last year. First quarter fiscal 2014 adjusted EBITDA excludes $500,000 of integration expenses and $1.28 million of CEO transition expense, while first quarter fiscal 2013 adjusted EBITDA excludes $577,000 in acquisition expenses. |
| • | | GAAP diluted earnings per share was $0.12 vs. $0.36 reported in the same period a year ago. First quarter EPS was adversely impacted by an increase of $960,000 in audit, tax and other professional service fees. |
| • | | Adjusted (non-GAAP) diluted EPS, which excludes integration expenses and CEO transition expense, was $0.22. |
Chris Fraser, KMG chairman and chief executive officer, said, “KMG achieved record quarterly revenue of $93.6 million in the first quarter, driven by our newly acquired UPC business. We have been pleased with the integration of the UPC business into our existing Electronic Chemicals business, and we continue to focus intensely on this initiative to ensure a seamless transition for our numerous customers in the global semiconductor industry.
“During the first quarter we announced a strategic manufacturing realignment of our global Electronic Chemicals business. Currently we are in the process of transferring production from the Fremont, California site primarily to our larger facilities in the U.S. In addition, we recently announced a consolidation plan for our European operations, involving the transfer of production from our Milan, Italy site to our other European facilities. We are confident these actions will yield enduring operating efficiencies for our global Electronic Chemicals business.”
Mr. Fraser continued, “In the first quarter, consolidated net income was negatively impacted by higher than anticipated audit, tax and professional service fees due to the coincident timing of the close of the UPC acquisition and our fiscal year-end filing. For the fiscal 2014 year, overall corporate overhead expense will be higher than last year’s level, reflecting the increased size and scope of our global operations.”
1 | Non-U.S. GAAP measure. See Table 1 for reconciliation. |
Phone: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG
First Quarter Results
| | | | | | | | | | | | | | | | |
Dollars in thousands, except EPS | | Fiscal 2014 | | | Fiscal 2013 | |
(unaudited) | | | | | As | | | | | | As | |
| | Adjusted | | | Reported | | | Adjusted | | | Reported | |
| | (non-GAAP) | | | (GAAP) | | | (non-GAAP) | | | (GAAP) | |
Net Sales | | $ | 93,560 | | | $ | 93,560 | | | $ | 65,336 | | | $ | 65,336 | |
Operating Income | | | 4,835 | | | | 3,055 | | | | 7,681 | | | | 7,104 | |
Operating Margin | | | 5.2 | % | | | 3.3 | % | | | 11.8 | % | | | 10.9 | % |
Net Income | | | 2,511 | | | | 1,352 | | | | 4,507 | | | | 4,142 | |
Diluted EPS | | $ | 0.22 | | | $ | 0.12 | | | $ | 0.39 | | | $ | 0.36 | |
Electronic Chemicals
First Quarter Results
| | | | | | | | | | | | |
Dollars in thousands | | Fiscal 2014 | | | Fiscal 2013 | |
| | | | | As | | | As | |
| | Adjusted | | | Reported | | | Reported | |
| | (non-GAAP) | | | (GAAP) | | | (GAAP) | |
Net Sales | | $ | 64,452 | | | $ | 64,452 | | | $ | 39,507 | |
Operating Income | | $ | 3,838 | | | | 3,338 | | | | 5,072 | |
Operating Margin | | | 6.0 | % | | | 5.2 | % | | | 12.8 | % |
For the first fiscal quarter, the Electronic Chemicals segment reported:
| • | | Sales of $64.5 million, up from $39.5 million in the same period a year ago. The increase in sales reflected the addition of the UPC business. Electronic Chemicals sales represented 69% of consolidated first quarter sales. |
| • | | Adjusted operating income of $3.8 million, vs. $5.1 million last year. Including integration expenses of $500,000, operating income was $3.3 million. |
| • | | Adjusted operating margin of 6.0% vs. 12.8% in the previous year. Including the impact of integration expenses, operating margin was 5.2%. |
| • | | Depreciation and amortization expense of $3.2 million, compared to $1.6 million last year. Depreciation and amortization increased due to the acquisition of UPC assets. |
Wood Treating Chemicals
Main: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG
First Quarter Results
| | | | | | | | |
Dollars in thousands | | Fiscal 2014 | | | Fiscal 2013 | |
| | As | | | As | |
| | Reported | | | Reported | |
| | (GAAP) | | | (GAAP) | |
Net Sales | | $ | 29,064 | | | $ | 25,700 | |
Operating Income | | | 2,505 | | | | 3,366 | |
Operating Margin | | | 8.6 | % | | | 13.1 | % |
For the first fiscal quarter, the Wood Treating Chemicals segment reported:
| • | | Sales of $29.1 million, up 13.1% from the same period a year ago. The sales increase was due to higher volumes to the rail tie treating market. Wood Treating Chemicals sales represented 31% of consolidated first quarter sales. |
| • | | Operating profit of $2.5 million, or 8.6% of sales, compared to $3.4 million, or 13.1% of sales, last year. The decrease in operating profit reflected a less favorable product mix. |
Outlook
For fiscal 2014, the company issued the following forecast:
| • | | Consistent with prior guidance, consolidated net sales are forecast to exceed $350 million, benefiting from the acquisition of the UPC business. |
| • | | Projected restructuring charges remain targeted at $4-5 million, partially offset by an estimated $2-3 million of restructuring-related synergies and commercial benefits. In addition, incremental capital expenditures of $2 million are expected to be incurred to accomplish these plans. |
| • | | Depreciation and amortization expense of approximately $15 million, up approximately $7 million from fiscal 2013. |
| • | | GAAP net income to decline from the level reported in fiscal 2013. |
Conference call
Date: Tuesday, December 10, 2013
Time: 10:00 am ET
Dial in: 800-901-5241 or 617-786-2963
Conference ID: 96194428
The conference call will be webcast live via the “Investors” section of the Company’s website athttp://kmgchemicals.com.
If you are unable to listen live, the conference call will be archived on the KMG website. A telephone replay of the call will also be available for one week, starting at 2:00 p.m. ET on December 10, 2013. To access the call, dial 888-286-8010 or 617-801-6888 using participant passcode 74745279.
Main: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG
About KMG
KMG Chemicals, Inc., through its subsidiaries, produces and distributes specialty chemicals to select markets. The Company grows by acquiring and optimizing stable chemical product lines and businesses with established production processes. Its current operations are focused on the electronic and industrial wood treatment chemical markets. For more information, visit the Company’s website athttp://kmgchemicals.com.
The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, the impact of competitive services and pricing and general economic risks and uncertainties.
Main: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
(In thousands, except for per share amounts)
| | | | | | | | |
| | Three Months Ended | |
| | October 31, | |
| | 2013 | | | 2012 | |
Net sales | | $ | 93,560 | | | $ | 65,336 | |
Cost of sales | | | 67,993 | | | | 45,248 | |
| | | | | | | | |
Gross profit | | | 25,567 | | | | 20,088 | |
| | | | | | | | |
Distribution expenses | | | 12,112 | | | | 7,053 | |
Selling, general and administrative expenses | | | 10,400 | | | | 5,931 | |
| | | | | | | | |
Operating income | | | 3,055 | | | | 7,104 | |
| | | | | | | | |
Other income (expense) | | | | | | | | |
Interest expense, net | | | (663 | ) | | | (411 | ) |
Other, net | | | (315 | ) | | | (50 | ) |
| | | | | | | | |
Total other expense, net | | | (978 | ) | | | (461 | ) |
| | | | | | | | |
Income from continuing operations before income taxes | | | 2,077 | | | | 6,643 | |
Provision for income taxes | | | (725 | ) | | | (2,435 | ) |
| | | | | | | | |
Income from continuing operations | | | 1,352 | | | | 4,208 | |
| | | | | | | | |
Discontinued operations | | | | | | | | |
Loss from discontinued operations, before income taxes | | | — | | | | (102 | ) |
Income tax benefit | | | — | | | | 36 | |
| | | | | | | | |
Loss from discontinued operations | | | — | | | | (66 | ) |
Net income | | $ | 1,352 | | | $ | 4,142 | |
| | | | | | | | |
Earnings per share: | | | | | | | | |
Basic | | | | | | | | |
Income from continuing operations | | $ | 0.12 | | | $ | 0.36 | |
Loss from discontinued operations | | | — | | | | — | |
| | | | | | | | |
Net income | | $ | 0.12 | | | $ | 0.36 | |
| | | | | | | | |
Diluted | | | | | | | | |
Income from continuing operations | | $ | 0.12 | | | $ | 0.36 | |
Loss from discontinued operations | | | — | | | | — | |
| | | | | | | | |
Net income | | $ | 0.12 | | | $ | 0.36 | |
| | | | | | | | |
Weighted average shares outstanding: | | | | | | | | |
Basic | | | 11,575 | | | | 11,436 | |
Diluted | | | 11,610 | | | | 11,564 | |
Main: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except for share and per share amounts)
| | | | | | | | |
| | October 31, | | | July 31, | |
| | 2013 | | | 2013 | |
| | (Unaudited) | | | | |
Assets | | | | | | | | |
Current assets | | | | | | | | |
Cash and cash equivalents | | $ | 13,410 | | | $ | 13,949 | |
Accounts receivable | | | | | | | | |
Trade, net of allowances of $244 at October 31, 2013 and $224 at July 31, 2013 | | | 43,608 | | | | 41,935 | |
Other | | | 3,227 | | | | 4,210 | |
Inventories, net | | | 48,875 | | | | 53,387 | |
Current deferred tax assets | | | 615 | | | | 1,400 | |
Prepaid expenses and other | | | 2,920 | | | | 3,955 | |
| | | | | | | | |
Total current assets | | | 112,655 | | | | 118,836 | |
| | | | | | | | |
Property, plant and equipment, net | | | 97,822 | | | | 96,688 | |
Deferred tax assets | | | 981 | | | | 1,069 | |
Goodwill | | | 11,181 | | | | 10,929 | |
Intangible assets, net | | | 29,087 | | | | 29,261 | |
Restricted cash | | | 1,000 | | | | 1,000 | |
Other assets, net | | | 4,228 | | | | 4,232 | |
| | | | | | | | |
Total assets | | $ | 256,954 | | | $ | 262,015 | |
| | | | | | | | |
Liabilities & stockholders’ equity | | | | | | | | |
Current liabilities | | | | | | | | |
Accounts payable | | $ | 26,469 | | | $ | 35,492 | |
Accrued liabilities | | | 10,264 | | | | 8,362 | |
Employee incentive accrual | | | 3,278 | | | | 1,989 | |
| | | | | | | | |
Total current liabilities | | | 40,011 | | | | 45,843 | |
| | | | | | | | |
Long-term debt, net of current maturities | | | 83,000 | | | | 85,000 | |
Deferred tax liabilities | | | 9,946 | | | | 11,462 | |
Other long-term liabilities | | | 2,490 | | | | 2,470 | |
| | | | | | | | |
Total liabilities | | | 135,447 | | | | 144,775 | |
| | | | | | | | |
Commitments and contingencies | | | | | | | | |
Stockholders’ equity | | | | | | | | |
Preferred stock, $.01 par value, 10,000,000 shares authorized, none issued | | | — | | | | — | |
Common stock, $.01 par value, 40,000,000 shares authorized, 11,590,618 shares issued and outstanding at October 31, 2013 and 11,522,321 shares issued and outstanding at July 31, 2013 | | | 116 | | | | 115 | |
Additional paid-in capital | | | 27,810 | | | | 26,689 | |
Accumulated other comprehensive loss | | | (364 | ) | | | (2,504 | ) |
Retained earnings | | | 93,945 | | | | 92,940 | |
| | | | | | | | |
Total stockholders’ equity | | | 121,507 | | | | 117,240 | |
| | | | | | | | |
Total liabilities and stockholders’ equity | | $ | 256,954 | | | $ | 262,015 | |
| | | | | | | | |
Main: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In thousands)
| | | | | | | | |
| | Three Months Ended | |
| | October 31, | |
| | 2013 | | | 2012 | |
Cash flows from operating activities | | | | | | | | |
Net income | | $ | 1,352 | | | $ | 4,142 | |
Adjustments to reconcile net income to net cash provided by operating activities | | | | | | | | |
Depreciation and amortization | | | 3,464 | | | | 1,757 | |
Amortization of loan costs included in interest expense | | | 15 | | | | 17 | |
Stock-based compensation expense | | | 1,243 | | | | 181 | |
Bad debt expense | | | 111 | | | | 73 | |
Inventory valuation adjustment | | | (41 | ) | | | (209 | ) |
Loss on disposal of property | | | 4 | | | | 9 | |
Loss on sale of animal health business | | | — | | | | 57 | |
Deferred income tax benefit | | | (820 | ) | | | (221 | ) |
Tax benefit from stock-based awards | | | (217 | ) | | | — | |
Changes in operating assets and liabilities | | | | | | | | |
Accounts receivable — trade | | | (1,182 | ) | | | 2,723 | |
Accounts receivable — other | | | 999 | | | | (315 | ) |
Inventories | | | 4,890 | | | | (5,038 | ) |
Other current and non-current assets | | | 1,910 | | | | 310 | |
Accounts payable | | | (9,806 | ) | | | 1,901 | |
Accrued liabilities and other | | | 2,068 | | | | 945 | |
| | | | | | | | |
Net cash provided by operating activities | | | 3,990 | | | | 6,332 | |
| | | | | | | | |
Cash flows from investing activities | | | | | | | | |
Additions to property, plant and equipment | | | (2,665 | ) | | | (1,523 | ) |
| | | | | | | | |
Net cash used in investing activities | | | (2,665 | ) | | | (1,523 | ) |
| | | | | | | | |
Cash flows from financing activities | | | | | | | | |
Net payments under revolving credit agreement | | | (2,000 | ) | | | (2,000 | ) |
Tax benefit from stock-based awards | | | 217 | | | | — | |
Payment of dividends | | | (347 | ) | | | (342 | ) |
| | | | | | | | |
Net cash used in financing activities | | | (2,130 | ) | | | (2,342 | ) |
| | | | | | | | |
Effect of exchange rate changes of cash | | | 266 | | | | 80 | |
Net increase (decrease) in cash and cash equivalents | | | (539 | ) | | | 2,547 | |
Cash and cash equivalents at beginning of period | | | 13,949 | | | | 1,633 | |
| | | | | | | | |
Cash and cash equivalents at end of period | | $ | 13,410 | | | $ | 4,180 | |
| | | | | | | | |
Main: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG
Reconciliation of non-GAAP financial measures to GAAP financial measures
KMG provides non-GAAP financial information to complement reported GAAP results. KMG believes that analysis of our financial performance would be enhanced by an understanding of the factors underlying that performance and our judgments about the likelihood that particular factors will repeat. Excluding expenses related to the integration of OM Group’s Ultra Pure Chemicals business and CEO transition expenses from current results will allow for more accurate comparisons of our operating performance. KMG intends to continue to provide certain non-GAAP financial information and the appropriate reconciliation to GAAP in its financial results. As required by SEC rules, the tables below present a reconciliation of our presented non-GAAP measures to the most directly comparable GAAP measures.
Reconciliation of Non-GAAP Financial Measures to GAAP Financial Measures
First Quarter Fiscal 2014
Dollars in thousands, except EPS
| | | | | | | | | | | | | | | | |
| | KMG Chemicals, Inc. | |
| | | | | | | | | | | Diluted | |
| | Operating | | | Net | | | Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
Non-GAAP measure | | $ | 4,835 | | | | 5.2 | % | | $ | 2,511 | | | $ | 0.22 | |
Acquisition & integration expenses | | | (500 | ) | | | (0.5 | %) | | | (326 | ) | | ($ | 0.03 | ) |
CEO transition costs | | | (1,280 | ) | | | (1.4 | %) | | | (833 | ) | | ($ | 0.07 | ) |
| | | | | | | | | | | | | | | | |
GAAP measure | | $ | 3,055 | | | | 3.3 | % | | $ | 1,352 | | | $ | 0.12 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | Electronic Chemicals | | | Wood Treating Chemicals | |
| | Operating | | | Operating | |
| | Income | | | Margin | | | Income | | | Margin | |
Non-GAAP measure | | $ | 3,838 | | | | 6.0 | % | | | — | | | | — | |
Integration expenses | | | (500 | ) | | | (0.8 | %) | | | — | | | | — | |
| | | | | | | | | | | | | | | | |
GAAP measure | | $ | 3,338 | | | | 5.2 | % | | $ | 2,505 | | | | 8.6 | % |
| | | | | | | | | | | | | | | | |
Table 1
UNAUDITED RECONCILIATION OF NET INCOME TO EBITDA AND ADJUSTED EBITDA
(In thousands)
| | | | | | | | |
| | Three months ended | |
| | October 31, | |
| | 2013 | | | 2012 | |
GAAP net income | | $ | 1,352 | | | $ | 4,142 | |
Interest expense | | | 663 | | | | 411 | |
Depreciation and amortization | | | 3,464 | | | | 1,757 | |
Income tax provision | | | 725 | | | | 2,399 | |
Discontinued operations | | | — | | | | — | |
| | | | | | | | |
EBITDA | | | 6,204 | | | | 8,709 | |
Unusual items impacting net income | | | | | | | | |
Acquisition and integration expenses | | | 500 | | | | 577 | |
CEO transition costs | | | 1,280 | | | | — | |
| | | | | | | | |
Adjusted EBITDA | | $ | 7,984 | | | $ | 9,286 | |
| | | | | | | | |
Main: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG
Source: KMG Chemicals, Inc.
KMG Chemicals, Inc.
Eric Glover, 713-600-3865
Investor Relations Manager
eglover@kmgchemicals.com
Main: 713-600-3800— Fax: 713-600-3850
www.kmgchemicals.com— NYSE: KMG